
Keywords: ASCT; autologous stem cell transplant; EMD; extramedullary disease; FLC; free light chain; ISS; International Staging System; KRD; carfilzomib, lenalidomide, and dexamethasone; MGUS; monoclonal gammopathy of undetermined significance; MM; multiple myeloma